Vycor Medical (VYCO) Common Equity (2010 - 2026)

Vycor Medical (VYCO) has 17 years of Common Equity data on file, last reported at -$4.2 million in Q1 2026.

• On a quarterly basis, Common Equity fell 8.69% year-over-year to -$4.2 million in Q1 2026; TTM through Mar 2026 was -$4.2 million, a 8.69% decrease from a year earlier, with the FY2025 full-year figure at -$4.1 million, down 10.75% from the prior year.
• Common Equity for Q1 2026 stood at -$4.2 million, down from -$4.1 million in the prior quarter.
• Over the last five years, Common Equity for VYCO reached as high as -$2.6 million in Q1 2022 and fell as low as -$4.2 million in Q1 2026.
• Historically, Common Equity has averaged -$3.4 million across 5 years, with a median of -$3.5 million in 2024.
• Across the five-year window, Common Equity slumped 222.78% in 2022 and fell 8.69% in 2026, its largest moves.
• Year by year, Common Equity stood at -$2.9 million in 2022, then declined by 13.08% to -$3.3 million in 2023, then dropped by 10.96% to -$3.7 million in 2024, then declined by 10.75% to -$4.1 million in 2025, then dropped by 3.48% to -$4.2 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were -$4.2 million in Q1 2026, -$4.1 million in Q4 2025, and -$4.0 million in Q3 2025.